Kent Imaging, Inc. recalls Snapshot NIR
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Tissue oxygenation measurement system touchscreens may be unresponsive, which may prevent the viewing of oxygenation images.
- Products
-
- Snapshot NIR
- Company
- Kent Imaging, Inc.
- Where it was sold
-
Worldwide - US Nationwide distribution in the states of IN, OH, TX, PA, WI, OR, CO, IL, MO, CA, AZ, IA and the countries of Malaysia.
States: Arizona, California, Colorado, Iowa, Illinois, Indiana, Missouri, Ohio, Oregon, Pennsylvania, Texas, Wisconsin
- Units affected
- 57
- About this recall
- Snapshot NIR, REF: KD204